Hatteras Venture Advisors III, LLC Insider Trading $PHAS PhaseBio Pharmaceuticals Inc

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Hatteras Venture Advisors III, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Hatteras Venture Advisors III, LLC. Hatteras Venture Advisors III, LLC is 10% Owner in PhaseBio Pharmaceuticals Inc ($PHAS) and 10% Owner in Clearside Biomedical, Inc. ($CLSD).

Hatteras Venture Advisors III, LLC in PhaseBio Pharmaceuticals Inc

Trading Symbol: PHAS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hatteras Venture Advisors III, LLC: 10% Owner
Holdings: 52,690 shares
Latest Transaction: Oct 24 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Hatteras Venture Advisors III, LLC in PhaseBio Pharmaceuticals Inc

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CLSD, PHAS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00226,06100
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0024,70900
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00272,10700
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0040,42000
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0013,55800
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00149,32000
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0094,87400
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.001,044,76400
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0013,60900
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.00174,69900
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.004,84600
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.003,86200
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0042,53000
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseC0.0052,69000
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseS0.00994040,420
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.0041,414041,414
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.1241,4144,9700
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseS0.00104013,558
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.004,309013,662
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.124,3095170
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseS0.001,1390149,320
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.0047,4580150,459
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.1247,4585,6950
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseS0.0042094,874
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.001,731094,916
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.121,7312080
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseS0.0045801,044,764
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.0019,06101,045,222
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerOption ExerciseX0.1219,0612,2870
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyP5.00150,000750,000416,481266.5 K to 416.5 K (+56.29 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyC0.00266,4810266,4810 to 266.5 K
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyC0.004,84604,8460 to 4.8 K
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyP5.0012,48762,435163,099150.6 K to 163.1 K (+8.29 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyC0.00150,6120150,6120 to 150.6 K
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyP5.00137,513687,5651,820,9331.7 M to 1.8 M (+8.17 %)
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyC0.001,683,42001,683,4200 to 1.7 M
Oct 24 2018PHASPhaseBio Pharmaceu ...Hatteras Venture Advisors III, ...10% OwnerBuyC0.0052,690052,6900 to 52.7 K

Page:   1